A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors
Clinical trial NCT00495144 · COMPLETED
Trial details
- NCT number
- NCT00495144
- Sponsor
- Threshold Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2011-12-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.